Copyright
©The Author(s) 2016.
World J Radiol. May 28, 2016; 8(5): 449-459
Published online May 28, 2016. doi: 10.4329/wjr.v8.i5.449
Published online May 28, 2016. doi: 10.4329/wjr.v8.i5.449
Feature | SIR-Spheres® | TheraSphere® |
Isotope | 90Y | 90Y |
Half life (h) | 64.2 | 64.2 |
Material | Resin | Glass |
Diameter (μm) | 20-60 | 20-30 |
Activity per particle (Bq) | 50 | 2500 |
Spheres per 3 GBq | 40-80 × 106 | 1.2 × 106 |
Specific Gravity (g/mL) | 1.6 | 3.2 |
Embolic effect | Mild | Negligible |
Contrast injection | During infusion | No |
FDA approved indication | CRC liver metastases with intrahepatic floxuridine | HCC |
- Citation: Mahnken AH. Current status of transarterial radioembolization. World J Radiol 2016; 8(5): 449-459
- URL: https://www.wjgnet.com/1949-8470/full/v8/i5/449.htm
- DOI: https://dx.doi.org/10.4329/wjr.v8.i5.449